ParvOryx

AXP000127.1 · Oncolytic virus

Platform
parvovirus H-1 (H-1PV, wild-type)
Originator
German Cancer Research Center (DKFZ)
Sponsor
Oryx GmbH

Names

NameTypeSource
ParvOryxpreferred name, brandcurator, ncit
H-1PV ambiguoussynonymncit

Virus

Role
Oncolytic
Family
Parvoviridae
Virus
H-1 parvovirus (NCBI Taxonomy 10799)
Strain
H-1PV (wild-type)
Replication
replicating
Modifications
none (wild-type)
Route
intratumoral, intravenous, intracerebral
Source
evidence

Cross-references

NCI Thesaurus
C96229

Approvals

No regulatory approval recorded.

Clinical trials (2)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT02653313Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic CancerCompletedPhase 1/22015-122018-057Carcinoma, Pancreatic Ductal
NCT01301430Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.CompletedPhase 1/22011-092015-0518Glioblastoma Multiforme

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 34426438Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research2021name in abstract: ParvOryx
PMID 28851316A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol.BMC cancer2017name in title: ParvOryx
PMID 22436661Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol.BMC cancer2012name in title: ParvOryx

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 34004331Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme.Seminars in cancer biology2022name in abstract: ParvOryx
PMID 31486047Fluorescence In Situ Hybridization (FISH) Detection of Viral Nucleic Acids in Oncolytic H-1 Parvovirus-Treated Human Brain Tumors.Methods in molecular biology (Clifton, N.J.)2020name in abstract: ParvOryx
PMID 30563098Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?Cancers2018name in abstract: ParvOryx
PMID 22642177[Oncolytic parvoviruses. A new approaches for cancer therapy].Vestnik Rossiiskoi akademii meditsinskikh nauk2012name in abstract: ParvOryx
Unconfirmed matches (16)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

PubMedTitleJournalYearLinked by
PMID 34071585Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer.Viruses2021name in title: H-1PV
PMID 31440242Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study.Frontiers in immunology2019name in title: H-1PV
PMID 29584637Mutations in the Non-Structural Protein-Coding Sequence of Protoparvovirus H-1PV Enhance the Fitness of the Virus and Show Key Benefits Regarding the Transduction Efficiency of Derived Vectors.Viruses2018name in title: H-1PV
PMID 29039746Preclinical Testing of an Oncolytic Parvovirus: Standard Protoparvovirus H-1PV Efficiently Induces Osteosarcoma Cell Lysis In Vitro.Viruses2017name in title: H-1PV
PMID 26658622Standardized large-scale H-1PV production process with efficient quality and quantity monitoring.Journal of virological methods2016name in title: H-1PV
PMID 24574398Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.Journal of virology2014name in title: H-1PV
PMID 23383065TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells.PloS one2013name in title: H-1PV
PMID 24092664Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas.EMBO molecular medicine2013name in title: H-1PV
PMID 24210118Capacity of wild-type and chemokine-armed parvovirus H-1PV for inhibiting neo-angiogenesis.Virology2013name in title: H-1PV
PMID 22258256Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid.Journal of virology2012name in title: H-1PV
PMID 22553326An in-frame deletion in the NS protein-coding sequence of parvovirus H-1PV efficiently stimulates export and infectivity of progeny virions.Journal of virology2012name in title: H-1PV
PMID 22024742Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer.Cancer biology & therapy2011name in title: H-1PV
PMID 19856310SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H-1PV.International journal of cancer2010name in title: H-1PV
PMID 21124075Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent.Cancer biology & therapy2010name in title: H-1PV
PMID 19147756Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV.Clinical cancer research : an official journal of the American Association for Cancer Research2009name in title: H-1PV
PMID 19367260Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies.Molecular therapy : the journal of the American Society of Gene Therapy2009name in title: H-1PV

Notes

Wild-type rat protoparvovirus H-1, unmodified. ParvOryx01 in glioblastoma used intratumoral/intracerebral and intravenous/intracerebral arms; ParvOryx02 treated pancreatic carcinoma. The only non-adenovirus, non-herpes, non-pox DNA virus found dosed in humans as an oncolytic.

How to cite

ParvOryx (AXP000127.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000127.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.